Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Upadacitinib effectively treats pyoderma gangrenosum.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Some natural compounds might help hair grow.

New treatments for skin diseases in 1979 showed promising results with fewer side effects.

DPK-060 in poloxamer gel effectively treats skin infections, but nanocarriers don't enhance its efficacy.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Minoxidil boosts hair cell growth, while cyclosporin does not.

Most patients with dermatomyositis had skin rash and were treated with prednisolone and hydroxychloroquine.

Polycystic ovarian disease symptoms can continue after menopause, making diagnosis and management in older women challenging.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Low-dose oral minoxidil may help with symptoms and hair regrowth in lichen planopilaris without serious side effects.

PMC shows promise as a treatment for hair loss.

New cytokine-targeted therapies show promise for treating alopecia areata.

A homeopathic antidandruff shampoo caused severe hair matting in a girl.

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Topical glucocorticoids thin the skin and change collagen structure.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.